Ultrasound technology startup Exo Imaging has raised $35 million in a series B financing round, increasing its investment total to nearly $50 million.
Exo said it aims to use the funds to finish developing a handheld ultrasound platform based on its piezoelectric micromachined ultrasound transducers (pMUT) technology and artificial intelligence (AI). The patented technology features a piezoelectric combination of nanomaterials, novel sensor technology, and advanced signal processing and computation, according to the vendor.
The platform, which will be suitable for both imaging and therapeutic applications, will be capable of producing 3D ultrasound scans with high image fidelity and penetration depth, according to the company.
Intel Capital led the new funding round, with investments from Applied Ventures, Bold Capital, Creative Ventures, Longevity Vision Fund, Magnetar Capital, Nautilus Venture Partners, OSF Healthcare, Rising Tide Fund, Sony Innovation Fund, and Wanxiang Healthcare Investments.
